| Amber K Helps, | |
|
303 Medical Center Dr, Batesville, MS 38606-8608 | |
| (662) 741-7721 | |
| Not Available |
| Full Name | Amber K Helps |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 303 Medical Center Dr, Batesville, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801073879 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT1328 (Mississippi) | Primary |
| Provider Name | Healthpro Heritage Rehab & Fitness Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1376073262 PECOS PAC ID: 6507832573 Enrollment ID: O20171003005084 |
News Archive
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
A new study by researchers at Strasbourg University Hospital and published on the preprint server medRxiv* in June 2020 shows that COVID-19 antibody responses may sometimes be lacking following exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This could lead to a significant underestimation of the number of infections and the number of individuals who have achieved immunity.
Many top hospitals in the United States are making it unduly confusing or expensive for patients to gain access to their own medical records, say researchers at Yale. Their study appeared on Oct. 5 in JAMA Network Open.
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS).
Timing is everything when it comes to the development of the vertebrate face. In a new study published in PLoS Genetics, USC Stem Cell researcher Lindsey Barske from the laboratory of Gage Crump and her colleagues identify the roles of key molecular signals that control this critical timing.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amber K Helps, 4743 Highway 51 S, Pope, MS 38658-7211 Ph: () - | Amber K Helps, 303 Medical Center Dr, Batesville, MS 38606-8608 Ph: (662) 741-7721 |
News Archive
Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer - either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.
A new study by researchers at Strasbourg University Hospital and published on the preprint server medRxiv* in June 2020 shows that COVID-19 antibody responses may sometimes be lacking following exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This could lead to a significant underestimation of the number of infections and the number of individuals who have achieved immunity.
Many top hospitals in the United States are making it unduly confusing or expensive for patients to gain access to their own medical records, say researchers at Yale. Their study appeared on Oct. 5 in JAMA Network Open.
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS).
Timing is everything when it comes to the development of the vertebrate face. In a new study published in PLoS Genetics, USC Stem Cell researcher Lindsey Barske from the laboratory of Gage Crump and her colleagues identify the roles of key molecular signals that control this critical timing.
› Verified 4 days ago
Mrs. Colleen Montgomery, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 640 Keating Rd, Batesville, MS 38606 Phone: 662-563-2345 | |
Michelle Cohen, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 171 Lakewood Dr Ste 2, Batesville, MS 38606 Phone: 662-563-2579 | |
Southern Hand Centers Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 156 Highway 51 S, Batesville, MS 38606 Phone: 662-578-2110 Fax: 662-578-2108 | |
Ferris O'bannon Mcguire, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 171 Lakewood Dr Ste 2, Batesville, MS 38606 Phone: 662-563-2579 | |
Chloe Bloom, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 640 Keating Rd, Batesville, MS 38606 Phone: 601-605-6777 | |
Stacy Melton, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 303 Medical Center Dr, Batesville, MS 38606 Phone: 662-712-7721 | |
Thrivenow Pediatric Therapy Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 191 Highway 51 S, Batesville, MS 38606 Phone: 662-292-8060 |